Patrick O'Donnell Joins Medical Capital Advisors

Monday, April 28, 2008 General News J E 4
WALTHAM, Mass., April 28 With over 16 years of medicaldevice commercialization and strategic marketing experience, PatrickO'Donnell joins Waltham, MA-based medical technology investment firm MedicalCapital Advisors as President and CEO of Curative Biosciences, Inc. and MobiusMedical Holding & Distribution Company, LLC. In this role, Mr. O'Donnell willoversee the early stage funding and strategic development of theseorganizations as well as oversee the development of their respectivetechnology platforms and implementation of commercial activities.

Prior to joining the Medical Capital Development team, Mr. O'Donnell ledthe global marketing organization for biomaterial medical device start-upcompany Confluent Surgical, Inc. While at Confluent Surgical, Mr. O'Donnellwas responsible for the global launch of the organization's flagship hydrogeltechnology, DuraSeal(TM), into the neurosurgical market through an independentsales network. Mr. O'Donnell was also responsible for building thetechnology's value in spine, thoracic, and vascular markets. In 2007, Mr.O'Donnell played a participatory role in the $245 million acquisition andsubsequent integration of Confluent Surgical by Tyco Healthcare, now Covidien.

Prior to Confluent Surgical, Mr. O'Donnell spent 13 years in the spine,orthobiologics, and orthopaedics industry at Johnson & Johnson's DePuy Spineprimarily in sales, sales management and marketing capacities.

Mr. O'Donnell received his B.A. degree from the University of Wisconsin-Madison and his addition to the multidisciplinary team further strengthensMedical Capital Advisors position as a leader in the medical technologyindustry.

About Medical Capital Group

Medical Capital Group is a healthcare merchant banking firm providingstrategic and investment banking services and financing to leading medicaltechnology and healthcare companies. Through deep domain expertise and amulti-disciplinary team approach, MedCap delivers a paramount level of marketinsight and client service to firms who wish to access capital through merger,acquisition, private equity/venture capital financing, or strategicpartnerships. For more information on Curative Biosciences or Mobius MedicalHolding & Distribution Company, please visit orcall (781) 839-7364.

SOURCE Medical Capital Group


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Prematics(TM) Adds David J. Brailer, MD, PhD, to B...
Caliper Life Sciences' Optical Imaging Technology ...